DHL Global Forwarding, the freight arm of Deutsche Post DHL Group, began certifying its global stations with the IATA CEIV Pharma Standard since 2016 and has recently recertified its air freight station in Singapore for another year.
“Singapore is the latest in our Asia Pacific network, along with Japan and China, to receive the IATA CEIV Pharma recertification. This is especially timely as several countries try to secure Covid-19 vaccines to put a halt to the economic and social impact of the pandemic,” said Kelvin Leung, CEO, DHL Global Forwarding Asia Pacific.
The IATA CEIV Pharma standard, run by International Air Transport Association (IATA), was designed to ensure compliance, standardization, accountability and transparency across the air transport supply chain.
At each location, IATA examines and compares the station’s correspondence to its temperature control regulations (TCR) as well as GDP (Good Distribution Practices) guidelines from the European Union, WHO and other regulatory bodies.
“As the freight forwarder that was involved with bringing in Singapore’s first batch of Covid-19 vaccines, DHL Global Forwarding places a huge emphasis on delivering the highest supply chain standards for our LSH customers,” said Christopher Lim, managing director, DHL Global Forwarding Singapore and Malaysia.
“The re-certification of the IATA CEIV Pharma on a corporate level and for our air freight station at Changi Airport stands testament to our commitment to support governments and the LSH sector during this crucial recovery period,” he added.
Following independent audits by third parties and training courses for employees on site, the DHL Air GxP (good practice) facility in Singapore successfully renewed the quality label by exceeding the usual quality standards for transportation and storage of pharmaceutical goods.